Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Steinberg

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 20, 2017
Gaps in Radiation Therapy Awareness: Results From an Educational Multi-institutional Survey of US Internal Medicine ResidentsNarek Shaverdian, Sun Mi Yoo, Ryan Cook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2025
Validation and Derivation of miRNA-Based Germline Signatures Predicting Radiation Toxicity in Prostate CancerAmar U Kishan, Kristen McGreevy, Luca Valle, et al.
Brachytherapy|February 15, 2013
Focal high-dose-rate brachytherapy: a dosimetric comparison of hemigland vs. conventional whole-gland treatmentMitchell Kamrava, Melody P Chung, Oluwatosin Kayode, et al.
International Journal of Radiation Oncology, Biology, Physics|January 4, 2025
Pelvic Regional Control With 25 Gy in 5 Fractions in Stereotactic Radiation Therapy for High-Risk Prostate Cancer: Pooled Prospective Outcomes From the SHARP ConsortiumVedang Murthy, Indranil Mallick, Priyamvada Maitre, et al.
Advances in Radiation Oncology|May 7, 2026
Automated Assessment of Nondosimetric Aspects of Prostate Radiation Therapy Treatment Quality in a Large Plan DatabaseJohn A Charters, Melissa Ghafarian, Yasin Abdulkadir, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 3, 2016
Plan quality and dosimetric association of patient-reported rectal and urinary toxicities for prostate stereotactic body radiotherapyX Sharon Qi, Jason P Wang, Caitlin L Gomez, et al.
Journal of Palliative Medicine|April 25, 2017
Considerations for Quality Improvement in Radiation Oncology Therapy for Patients with Uncomplicated Painful Bone MetastasesAnne M Walling, Phillip J Beron, Tania Kaprealian, et al.
The British Journal of Radiology|January 15, 2016
The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapyNarek Shaverdian, Stephen Tenn, Darlene Veruttipong, et al.
Practical Radiation Oncology|July 12, 2014
Feasibility of prostate robotic radiation therapy on conventional C-arm linacsPeng Dong, Dan Nguyen, Dan Ruan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2013
Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trialsChristopher R King, Debra Freeman, Irving Kaplan, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
International Journal of Radiation Oncology, Biology, Physics|July 20, 2017
Gaps in Radiation Therapy Awareness: Results From an Educational Multi-institutional Survey of US Internal Medicine ResidentsNarek Shaverdian, Sun Mi Yoo, Ryan Cook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2025
Validation and Derivation of miRNA-Based Germline Signatures Predicting Radiation Toxicity in Prostate CancerAmar U Kishan, Kristen McGreevy, Luca Valle, et al.
Brachytherapy|February 15, 2013
Focal high-dose-rate brachytherapy: a dosimetric comparison of hemigland vs. conventional whole-gland treatmentMitchell Kamrava, Melody P Chung, Oluwatosin Kayode, et al.
International Journal of Radiation Oncology, Biology, Physics|January 4, 2025
Pelvic Regional Control With 25 Gy in 5 Fractions in Stereotactic Radiation Therapy for High-Risk Prostate Cancer: Pooled Prospective Outcomes From the SHARP ConsortiumVedang Murthy, Indranil Mallick, Priyamvada Maitre, et al.
Advances in Radiation Oncology|May 7, 2026
Automated Assessment of Nondosimetric Aspects of Prostate Radiation Therapy Treatment Quality in a Large Plan DatabaseJohn A Charters, Melissa Ghafarian, Yasin Abdulkadir, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 3, 2016
Plan quality and dosimetric association of patient-reported rectal and urinary toxicities for prostate stereotactic body radiotherapyX Sharon Qi, Jason P Wang, Caitlin L Gomez, et al.
Journal of Palliative Medicine|April 25, 2017
Considerations for Quality Improvement in Radiation Oncology Therapy for Patients with Uncomplicated Painful Bone MetastasesAnne M Walling, Phillip J Beron, Tania Kaprealian, et al.
The British Journal of Radiology|January 15, 2016
The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapyNarek Shaverdian, Stephen Tenn, Darlene Veruttipong, et al.
Practical Radiation Oncology|July 12, 2014
Feasibility of prostate robotic radiation therapy on conventional C-arm linacsPeng Dong, Dan Nguyen, Dan Ruan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2013
Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trialsChristopher R King, Debra Freeman, Irving Kaplan, et al.
Pageof 10